Private stocks deliver shot in the arm for International Biotechnology

Private stocks deliver shot in the arm for International Biotechnology

Unquoted investments dispensed double-digit returns for International Biotechnology Trust (IBT) during its 25th year, while its quoted investments bled capital amid the wider biotech market sell-off. The £227 million trust made 16.3% from its unquoted portfolio during...

Top 100 Funds 2019: Specialist equity funds

If you have a large portfolio and a higher risk appetite, you could consider adding a small allocation to some specialist equities funds focused on a particular area that could benefit from high growth. We have funds focused on the healthcare, technology, financials...
The trust led by a doctor with a prescription for healthy profit

The trust led by a doctor with a prescription for healthy profit

You  would usually want a qualified doctor to look after your health rather than your wealth, but Doctor Carl Harald Janson is the exception.   For the past 13 years, Janson, who qualified as a medical doctor 38 years ago, has devoted his working life to...
Fund Focus: International Biotech Trust

Fund Focus: International Biotech Trust

What it does Invests in companies developing new drugs. The team believe that an ageing global population means there is a growing need for these. What it invests in It looks for companies with an experienced management team targeting an unmet need. About 41% of its...

Disclaimer

  • You are seeing this because you are accessing IBT’s website for the first time.

 

  • The information on this website may only be suitable for certain types of investors and is not intended to be used or relied upon by any other person.

 

  • An investment with IBT may contain significant risks and is intended only for sophisticated investors who meet certain eligibility criteria.

 

  • The material on this website is intended to be viewed only by persons resident in the EEA.

 

  • The information on this website is not an offer to sell or a solicitation of an offer and does not constitute investment advice.

 

  • No representation, warranty or undertaking, express or implied, is given as to the accuracy or completeness of the information or opinions contained therein.

 

  • The information on this website may constitute financial promotion for the purposes of the Financial Services and Markets Act 2000 (“FSMA”).